Home/Filings/4/0001127602-22-007285
4//SEC Filing

Gaines Kristin Sallee 4

Accession 0001127602-22-007285

CIK 0000877860other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 3:26 PM ET

Size

23.1 KB

Accession

0001127602-22-007285

Insider Transaction Report

Form 4
Period: 2022-02-25
Gaines Kristin Sallee
Chief Credit Officer
Transactions
  • Award

    Stock Option (Right to buy) 2022

    2022-02-25$53.41/sh+18,333$979,16618,333 total
    Exercise: $53.41From: 2022-02-25Exp: 2027-02-25Common Stock (18,333 underlying)
  • Award

    Stock Option (Right to buy) 2022

    2022-02-25$53.41/sh+18,333$979,16618,333 total
    Exercise: $53.41From: 2023-02-25Exp: 2027-02-25Common Stock (18,333 underlying)
  • Award

    Stock Option (Right to buy) 2022

    2022-02-25$53.41/sh+18,334$979,21918,334 total
    Exercise: $53.41From: 2024-02-25Exp: 2027-02-25Common Stock (18,334 underlying)
Holdings
  • Stock Options (Right to Buy) 2019

    Exercise: $79.96From: 2019-02-21Exp: 2024-02-21Common Stock (18,333 underlying)
    18,333
  • Stock Options (Right to Buy) 2019

    Exercise: $79.96From: 2021-02-21Exp: 2024-02-21Common Stock (18,334 underlying)
    18,334
  • Stock Options (Right to Buy) 2-21-2020

    Exercise: $90.79From: 2022-02-21Exp: 2025-02-21Common Stock (18,334 underlying)
    18,334
  • Stock Options (Right to Buy) 2-25-2021

    Exercise: $69.20From: 2023-02-25Exp: 2026-02-25Common Stock (18,334 underlying)
    18,334
  • Common Stock

    44,609
  • Stock Options (Right to Buy) 2-21-2020

    Exercise: $90.79From: 2020-02-21Exp: 2025-02-21Common Stock (18,333 underlying)
    18,333
  • Stock Options (Right to Buy) 2-25-2021

    Exercise: $69.20From: 2021-02-25Exp: 2026-02-25Common Stock (18,333 underlying)
    18,333
  • Stock Options (Right to Buy) 2-21-2020

    Exercise: $90.79From: 2021-02-21Exp: 2025-02-21Common Stock (18,333 underlying)
    18,333
  • Stock Options (Right to Buy) 2-20-18

    Exercise: $64.33From: 2020-02-20Exp: 2023-02-20Common Stock (16,668 underlying)
    16,668
  • Stock Options (Right to Buy) 2019

    Exercise: $79.96From: 2020-02-21Exp: 2024-02-21Common Stock (18,333 underlying)
    18,333
  • Stock Options (Right to Buy) 2-25-2021

    Exercise: $69.20From: 2022-02-25Exp: 2026-02-25Common Stock (18,333 underlying)
    18,333
  • Stock Options (Right to Buy) 2-20-18

    Exercise: $64.33From: 2019-02-20Exp: 2023-02-20Common Stock (16,666 underlying)
    16,666

Issuer

NATIONAL HEALTH INVESTORS INC

CIK 0000877860

Entity typeother

Related Parties

1
  • filerCIK 0001455833

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 3:26 PM ET
Size
23.1 KB